A detailed history of Gateway Investment Advisers LLC transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Gateway Investment Advisers LLC holds 2,148 shares of JAZZ stock, worth $222,382. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,148
Previous 2,190 1.92%
Holding current value
$222,382
Previous $269,000 4.09%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

SELL
$115.19 - $132.77 $4,837 - $5,576
-42 Reduced 1.92%
2,148 $258,000
Q4 2023

Jan 09, 2024

SELL
$114.26 - $136.0 $1.46 Million - $1.74 Million
-12,816 Reduced 85.41%
2,190 $269,000
Q3 2023

Oct 19, 2023

SELL
$122.0 - $145.31 $2,074 - $2,470
-17 Reduced 0.11%
15,006 $1.94 Million
Q2 2023

Jul 13, 2023

SELL
$122.5 - $147.16 $735 - $882
-6 Reduced 0.04%
15,023 $1.86 Million
Q1 2023

Apr 11, 2023

SELL
$133.98 - $160.47 $33,227 - $39,796
-248 Reduced 1.62%
15,029 $2.2 Million
Q4 2022

Jan 13, 2023

BUY
$129.72 - $159.85 $21,663 - $26,694
167 Added 1.11%
15,277 $0
Q3 2022

Oct 07, 2022

SELL
$126.59 - $161.18 $21,140 - $26,917
-167 Reduced 1.09%
15,110 $2.01 Million
Q1 2022

Apr 14, 2022

BUY
$129.64 - $160.7 $8,296 - $10,284
64 Added 0.42%
15,277 $2.38 Million
Q4 2021

Jan 14, 2022

BUY
$119.87 - $145.67 $1.59 Million - $1.93 Million
13,240 Added 671.06%
15,213 $1.94 Million
Q3 2021

Oct 22, 2021

BUY
$128.64 - $184.79 $643 - $923
5 Added 0.25%
1,973 $257,000
Q1 2021

Apr 14, 2021

BUY
$150.19 - $173.5 $7,359 - $8,501
49 Added 2.55%
1,968 $323,000
Q4 2020

Jan 14, 2021

SELL
$140.71 - $165.05 $2,532 - $2,970
-18 Reduced 0.93%
1,919 $317,000
Q3 2020

Oct 19, 2020

SELL
$105.46 - $144.13 $2.17 Million - $2.97 Million
-20,613 Reduced 91.41%
1,937 $276,000
Q2 2020

Jul 15, 2020

SELL
$95.68 - $121.88 $370,185 - $471,553
-3,869 Reduced 14.64%
22,550 $2.49 Million
Q1 2020

Apr 13, 2020

SELL
$87.74 - $152.74 $2,018 - $3,513
-23 Reduced 0.09%
26,419 $2.64 Million
Q4 2019

Jan 09, 2020

SELL
$117.65 - $153.73 $224,829 - $293,778
-1,911 Reduced 6.74%
26,442 $3.95 Million
Q3 2019

Oct 15, 2019

BUY
$125.18 - $143.24 $5,507 - $6,302
44 Added 0.16%
28,353 $3.63 Million
Q2 2019

Jul 17, 2019

SELL
$125.55 - $144.48 $1,381 - $1,589
-11 Reduced 0.04%
28,309 $4.04 Million
Q1 2019

Apr 10, 2019

SELL
$121.81 - $142.95 $65,411 - $76,764
-537 Reduced 1.86%
28,320 $4.05 Million
Q4 2018

Jan 14, 2019

BUY
$115.94 - $166.74 $101,447 - $145,897
875 Added 3.13%
28,857 $3.58 Million
Q3 2018

Oct 16, 2018

SELL
$161.01 - $180.57 $23,990 - $26,904
-149 Reduced 0.53%
27,982 $4.71 Million
Q2 2018

Jul 11, 2018

SELL
$146.33 - $183.18 $1.65 Million - $2.07 Million
-11,295 Reduced 28.65%
28,131 $4.85 Million
Q1 2018

Apr 12, 2018

SELL
$135.59 - $157.16 $1.98 Million - $2.29 Million
-14,598 Reduced 27.02%
39,426 $5.95 Million
Q4 2017

Jan 17, 2018

BUY
$131.06 - $150.39 $2.92 Million - $3.35 Million
22,253 Added 70.04%
54,024 $7.27 Million
Q3 2017

Oct 16, 2017

BUY
$142.62 - $155.6 $4.53 Million - $4.94 Million
31,771
31,771 $4.65 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $6.49B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Gateway Investment Advisers LLC Portfolio

Follow Gateway Investment Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gateway Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gateway Investment Advisers LLC with notifications on news.